Editorial

Show 41-50 of 100 results

13 Sep 2021 : Editorial

Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP)

Dinah V. Parums,

DOI: 10.12659/MSM.934676

06 Sep 2021 : Editorial

Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy

Dinah V. Parums,

DOI: 10.12659/MSM.934625

30 Aug 2021 : Editorial

Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021

Dinah V. Parums,

DOI: 10.12659/MSM.934514

23 Aug 2021 : Editorial

Editorial: Review Articles, Systematic Reviews, Meta-Analysis, and the Updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Guidelines

Dinah V. Parums,

DOI: 10.12659/MSM.934475

16 Aug 2021 : Editorial

Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934393

09 Aug 2021 : Editorial

Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis

Dinah V. Parums,

DOI: 10.12659/MSM.934292

02 Aug 2021 : Editorial

Editorial: The National COVID Cohort Collaborative Consortium Combines Population Data with Machine Learning to Evaluate and Predict Risk Factors for the Severity of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934171

26 Jul 2021 : Editorial

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein

Dinah V. Parums,

DOI: 10.12659/MSM.934077

19 Jul 2021 : Editorial

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.933973

12 Jul 2021 : Editorial

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)

Nahum Méndez-Sánchez, Luis Enrique Díaz-Orozco

DOI: 10.12659/MSM.933860